Regulatory Focus: Week in Review (14-18 May)
Posted 18 May 2012 | By
Regulatory Focus is proud to bring you another edition of Week in Review-a recap of the global regulatory news space for the preceding week. We cover the news and regulatory intelligence from around the globe and bring it to you in one organized location. If you read just one thing this week, make it Regulatory Focus' Week in Review.
Previous Week in Reviews: [7-11 May] [1-4 May] [23-27 April] [16-20 April] [9-13 April]
Top News Items
White House Throws Support Behind Senate User Fee Bill (Regulatory Focus)
The Obama Administration has indicated it "strongly supports passage" of user fee legislation currently in the US Senate, saying it will "help speed safe and effective drugs, medical devices and biosimilar biological products to patients."
FDA Quicker Than EMA, Health Canada for Drug Approvals, Says NEJM Report (Regulatory Focus)
A study published in the New England Journal of Medicine claims the US Food and Drug Administration (FDA) approves drugs faster than the European Medicines Agency (EMA) or Health Canada.
European Parliament Still Dissatisfied With EMA Conflict of Interest Policies (Regulatory Focus)
The European Parliament is still refusing to sign off on the European Medicines Agency's (EMA) 2010 budget expenditures, the latest development in a long-running fight over the agency's credibility, reports Science Magazine.
Report: 'Dramatic' Increase in Q1 Medical Device Recalls (Regulatory Focus)
A new report tracking medical device recalls during the first quarter of 2012 shows a massive spike in medical device recalls, reversing a fourth quarter (Q4) 2011 trend of reduced recalls.
Regulatory Focus Features
FDA Information: Medical Devices
FDA Information: Pharmaceutical and Biologics
FDA Information: Other News
Other US News
Compliance and Safety Issues
Workshops & Meetings
Deals and Acquisitions
Regulation and Guidance
Other EU News
Global Regulatory News
Important Studies, Whitepapers and Research
Other News and Interesting Reads